Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Melody Petersen covered the pharmaceutical beat for The New York Times for four years. In 1997, her investigative reporting won a Gerald Loeb Award, one of the highest honors in business journalism. She is the author of Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines …
Diagnosing multi drug-resistant tuberculosis (MDR-TB) will now take just two days' time. In a major announcement on Monday, the World Health Organisation decided to make widely available a path-breaking rapid molecular diagnostic tool that will generate TB test results in two days flat. Currently, standard tests take up to three …
GURCHARAN DAS For some years now i have been on the board of Ranbaxy and have watched with admiration as the company transformed itself into India's first real multinational. I have seen it inspire a dozen other companies and helped create a world-class generic drugs industry that is feared by …
Crippling epidemics of meningococcal meningitis sweep across Africa with the onset of the dry season and harsh harmattan winds. An affordable, effective vaccine in the works could change that.
CABINET DECISIONS DAP has been brought on a par with imports for calculating concessions. The Cabinet Committee on Economic Affairs (CCEA) today approved a new concession scheme for phosphatic and potassic (P&K;) fertilisers that would reduce subsidy bill by Rs 1,163 crore, besides providing incentives to the industry to increase …
SUN Pharmaceutical Industries, the country's most valuable drugmaker, has decided to launch a hostile bid for Israel's Taro Pharmaceutical Industries. This is a rare instance of an Indian company making an unsolicited bid for a foreign firm. The move follows Taro's rejection of a merger agreement with Sun last month. …
Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market the generic version of Roche's Valcyte (valganciclovir hydrochloride Tablets, 450 mg), a drug used for treatment of cytomegalovirus retinitis in patients afflicted with AIDS. Being the first company to apply for the marketing …
Scientists in Australia claim to have created the world's first library of shark antibodies that have been modified to target diseases, like malaria, and could lead to new treatments. According to them, the process involves taking genes from sharks and modifying them in a laboratory just by adding proteins that …
Has Malvinder Singh truly freed Ranbaxy from risk by opting for an out-of-court settlement with Pfizer over Lipitor as he has claimed? The markets and analysts certainly thought otherwise. Investors dumped the Ranbaxy stock last week after the company announced that it had closed the feud with Pfizer over cholesterol …
Israel-based Taro Pharmaceuticals has sued its proposed buyer Sun Pharmaceutical Industries in an Israel court, for allegedly thwarting attempts to sell off Taro's subsidiary with drug-making facilities in Ireland to a group of investors. In a letter to Taro shareholders, the firm's Chairman Barrie Levitt said on June 15 that …
In a decision that will go a long way in soothing people living with HIV/AIDS (PLHAs), the Indian patent office today turned down the claim of a drug company to patent nevirapine. The drug is critical to HIV/AIDS treatment strategy, and is a crucial part of treatment for children affected …
Subject to the approval of the shareholders and the usual regulatory and statutory rubber stamps, India's largest pharmaceutical company, Ranbaxy Laboratories, is expected, by the end of March 2009 to become a subsidiary of Daiichi Sankyo, one of the leading pharmaceutical companies of Japan. Ranbaxy came into existence in 1937 …
After successful clinical trials in Latin America and England, vaccine to fight rotavirus to hit Indian markets in July A new vaccine to fight rotavirus is set to hit the Indian markets in the second week of July. Rotavirus is the leading cause of severe diarrhoea among infants and young …
Plasmodium vivax, a strain of malaria thought to be mild and non-life-threatening is potentially fatal, according to a new study. Two malaria strains, P. vivax and P. falciparum, affect humans. The latter, the dominant strain in Africa, is considered to be more virulent and deadlier. But P. vivax accounts for …
In sharp contrast to Europe, India takes the Ranbaxy sale in its stride: maturely and realistically Enough time has passed, sufficient dust has settled, since last Wednesday's announcement of Ranbaxy's sale of control to Daiichi Sankyo, to conclude that Indian reactions to the deal have been in marked and welcome …
Biopharma major Biocon is planning to set up a dedicated greenfield facility to manufacture tablet formulations. The Bangalore-based company currently outsources this activity. Biocon is in the tablet formulation market in a small way now across the nephrology, diabetology, cardiology and oncology verticals. This segment accounts for about 10% of …
Rising research and development(R&D;) initiatives in the pharma sector has made India a more mature place for drug discovery activities than China, says a report. Further, the report prepared by US-based Ewing Marion Kauffman Foundation noted that Indian companies are playing a strategic role in early drug discovery processes due …
>> The Spanish police have arrested five hackers they describe as being among the most active on the Internet. The hackers, who include two 16-year-olds, are accused of disrupting government websites in the US, Asia and Latin America. Police say they co-ordinated attacks over the Internet and hacked into 21,000 …
The Access to Medicine Foundation, based in Haarlem, the Netherlands, has developed a set of criteria to assess how ethically pharmaceutical companies perform towards developing countries. It will make its ranking available online from 16 June and hopes investors will use it to decide which companies to invest in, while …
